Skip to content

AC Immune SA

ACIU· NasdaqCore metricsCIK 1651625

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -5.31%
Market cap
$217.73M
101.74M shares
Filings
313
CHF 3.57M
FY 2025−86.9% FY25 yoy
-CHF 70.45M
FY 2025N/M FY25 yoy
-CHF 69.32M
FY 2025N/M FY25 yoy
-CHF 70.16M
FY 2025derivedN/M FY25 yoy
-CHF 0.70
FY 2025N/M FY25 yoy
CHF 26.80M
FY 2025−26.1% FY25 yoy
$217.73M
—
—
—
—
—

Price

$2.1436.87%$1.25past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

CHF 3.57MFY 2025
CHF 110.46M0FY 2015FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31CHF 3,573,000reported
FY 20242024-12-31CHF 27,309,000reported
FY 20232023-12-31CHF 14,801,000reported
FY 20222022-12-31CHF 3,935,000reported
FY 20212021-12-31CHF 0reported
FY 20202020-12-31CHF 15,431,000reported
FY 20192019-12-31CHF 110,456,000 revisedreported
FY 20182018-12-31CHF 6,912,000 revisedreported
FY 20172017-12-31CHF 20,255,000reported
FY 20162016-12-31CHF 23,214,000reported
FY 20152015-12-31CHF 39,090,000reported

Capital returns

Dividends and buybacks · FY2018 to FY2022
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2022—CHF 0.00CHF 0.00—83.62M sh+0.2%—
FY2021—CHF 0.00CHF 0.00—83.48M sh+16.0%—
FY2020—CHF 100.00KCHF 100.00K—71.94M sh+0.1%—
FY2019—CHF 0.00CHF 0.00—71.86M sh+6.4%0.0%
FY2018—CHF 0.00CHF 0.00—67.56M sh+17.8%—

Pharmaceutical preparations

AC Immune SA is the 245th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

AC Immune SA · CIK 1651625 · Engraved from SEC EDGAR